Quimiging, Lenie .

HRN: 11-72-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 1.5GM (VIAL)
09/24/2025
09/30/2025
IV
1.5 G
Q8H
UTI
Checking Initial Appropriateness 
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/02/2025
IV
500mg
Q8h
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: